Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples